CLINICAL_TRIALS
trial_result
· 2020-04-03
Clinical Trial Update: A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma [Phase 2]
Summary
Phase 2 trial update for GC33 (RO5137382) in advanced or metastatic hepatocellular carcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: COMPLETED